United States · FDA National Drug Code directory

Lamotrigine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68382-981_f4f7fc12-39cf-4974-80b3-d077e503bb90
Product NDC: 68382-981
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Lamotrigine
Labeler: Zydus Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20200514
Source listing expiry: 20261231

Source-listed ingredients

LAMOTRIGINE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-05) · 68382-981-05
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-06) · 68382-981-06
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-16) · 68382-981-16

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →